标题
Endocannabinoids modulate human blood-brain barrier permeabilityin vitro
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 12, Pages 3015-3027
出版商
Wiley
发表日期
2015-02-05
DOI
10.1111/bph.13106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transport of endocannabinoids across the plasma membrane and within the cell
- (2013) Christopher J. Fowler FEBS Journal
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
- (2012) Alexandra Wojtalla et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice
- (2012) Akbar Ahmad et al. BRAIN BEHAVIOR AND IMMUNITY
- Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats
- (2012) Akbar Ahmad et al. BRAIN RESEARCH
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
- (2012) Peter S. Amenta et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α
- (2012) Yu Zhou et al. NEUROPHARMACOLOGY
- Cannabinoid receptors: nomenclature and pharmacological principles
- (2012) Linda Console-Bram et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
- (2011) A Alhamoruni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fatty Acid-binding Proteins TransportN-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors
- (2011) Martin Kaczocha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors
- (2011) Leyre Mestre et al. Journal of Neuroinflammation
- Calcitonin gene-related peptide prevents blood–brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion
- (2011) Zhen Liu et al. REGULATORY PEPTIDES
- Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
- (2010) A. Alhamoruni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Possible Anandamide and Palmitoylethanolamide involvement in human stroke
- (2010) Marcello Naccarato et al. Lipids in Health and Disease
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
- (2010) Maria Teresa Cencioni et al. PLoS One
- Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death
- (2009) Cassandra I. Saunders et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans
- (2009) Marcus Schley et al. BRAIN RESEARCH BULLETIN
- Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier
- (2009) Caroline Mysiorek et al. CURRENT NEUROVASCULAR RESEARCH
- Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability
- (2009) C. L. Allen et al. DIABETES OBESITY & METABOLISM
- PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
- (2009) Wen Huang et al. FASEB JOURNAL
- A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
- (2009) N. T. Snider et al. MOLECULAR PHARMACOLOGY
- Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System
- (2009) Qiang Wang et al. STROKE
- Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
- (2008) Cecilia Hillard CURRENT PHARMACEUTICAL DESIGN
- Quantitative Real-Time PCR Detection of TRPV1–4 Gene Expression in Human Leukocytes from Healthy and Hyposensitive Subjects
- (2008) Giacomo Spinsanti et al. Molecular Pain
- Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide
- (2008) Dan Luo et al. REGULATORY PEPTIDES
- The complications of promiscuity: endocannabinoid action and metabolism
- (2007) S P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
- (2007) S E O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started